About this journal
Aims and scope
Expert Review of Proteomics [ISSN 1478-9450]; [e-ISSN 1744-8387] is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles and original research focusing on clinical aspects of proteomics. The journal publishes both Gold Open Access and Subscription content.
Expert Review of Proteomics publishes reviews, commentary and original research from the fields of clinical and translational proteomics and related fields to advance scientific understanding of the many varied roles protein expression plays in human health and disease. Papers focus on studies of the following to understand their role in clinical health (including how these can advance therapeutics) and the value that this has for precision medicine and patients generally:
- Biological pathways and proteins on a human cellular and tissue level
- Functional and structural proteomics
- Quantitative and qualitative profiling
- Evaluations, recent advancements, discoveries, observation, applications, implications, interactions, diagnostics, prognostics, proteomic profiling techniques and technological developments in the following:
- Biological mass spectrometry
- Protein arrays
- Interaction maps
- Data archives
- Biological assays
- Performance of new technologies and prospects for future drug discovery
We encourage articles that discuss the combination of proteomics with lipidomics, glycomics, metabolomics, epigenomics and multi-omics. Please note that the journal does not publish case reports or case series.
Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;
Article Highlights – an executive summary of the author’s most critical points.
For any pre-submission enquiries, please contact the Commissioning Editor.
Journal metrics
Usage
- 141K annual downloads/views
Citation metrics
- 3.8 (2023) Impact Factor
- Q1 Impact Factor Best Quartile
- 4.4 (2023) 5 year IF
- 7.6 (2023) CiteScore (Scopus)
- Q2 CiteScore Best Quartile
- 0.740 (2023) SNIP
- 0.985 (2023) SJR
Speed/acceptance
- 17 days avg. from submission to first decision
- 8 days avg. from acceptance to online publication
- 57% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Co-Editors
Christoph Borchers, Lady Davis Institute for Medical Research, Quebec, Canada
Rene Zahedi, Lady Davis Institute for Medical Research, Quebec, Canada
Editorial Board
Geert Baggerman, VITO (Flemish Institute for Technological Research), Belgium
Jonathan Blackburn, University of Cape Town, South Africa
Richard Burchmore, University of Glasgow, UK
William Cho, Queen Elizabeth Hospital, Hong Kong
Jasminka Godovac Zimmermann, University College London, United Kingdom
Canhua Huang, National Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
Thomas Joos, University of Tuebingen, Germany
Tadashi Kondo, National Cancer Center Research Institute, Japan
Lydie Lane, wiss Institute of Bioinformatics, Switzerland
Lance Liotta, George Mason University, VA, USA
Stefania Mondello, University of Messina, Messina, Italy
Kazuyuki Nakamura, Yamaguchi University School of Medicine, Japan
Edouard Nice, Monash University, Australia
Andrew Ottens, Virginia Commonwealth University, VA, USA
Emanuel Petricoin III, George Mason University, VA, USA
Wei-Jun Qian, Pacific Northwest National Laboratory, Richland, WA, USA
Om Singh, The Johns Hopkins School of Medicine, MD, USA
Gary Smejkal, Hubbard Center for Genome Studies, University of New Hampshire, Durham, NH, USA
Christopher Southan, IUPHAR Database, TW2Informatics, Sweden
Visith Thongboonkerd, Mahidol University, Thailand
Rui Vitorino, University of Aveiro, Portugal
Kui Wang, National Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
Tesshi Yamada, National Cancer Center Research Institute, Japan
Petra Zürbig, mosaiques diagnostics GmbH, Hannover, Germany
Abstracting and indexing
Expert Review of Proteomics
is included in the following abstracting and indexing services:EMBASE/Excerpta Medica; Biological Abstracts; Biobase; BIOSIS Previews; Chemical Abstracts; EMBASE/Excerpta Medica; Index to Scientific Reviews®; Journal Citation Reports/Science Edition; MEDLINE/Index Medicus; Science Citation Index Expanded™ (SciSearch®); Scopus.
Open access
Expert Review of Proteomics is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Use our APC finder to calculate your article publishing charge
News, offers and calls for papers
News and offers
12 issues per year
Associated with:
Advertising information
Would you like to advertise in Expert Review of Proteomics?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Expert Review of Proteomics.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors